MAGNESIUM 7D70-20 and 7D70-30 30-3864/R10 MAGNESIUM This package insert contains information to run the Magnesium assay on the ARCHITECT c Systems™ and the AEROSET System. NOTE: Changes Highlighted NOTE: This package insert must be read carefully prior to product use. Package insert instructions must be followed accordingly. Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in this package insert. Customer Support United States: Canada: International: 1-877-4ABBOTT 1-800-387-8378 (English speaking customers) 1-800-465-2675 (French speaking customers) Call your local Abbott representative Symbols in Product Labeling Calibrators 1 and 2 Catalog number/List number Concentration Serial number Authorized Representative in the European Community Consult instructions for use Ingredients Manufacturer In vitro diagnostic medical device Temperature limitation Batch code/Lot number Use by/Expiration date Reagent 1 ABBOTT LABORATORIES Abbott Park, IL 60064, USA ABBOTT Max-Planck-Ring 2 65205 Wiesbaden Germany +49-6122-580 September 2006 ©2002, 2006 Abbott Laboratories 1 NAME WARNINGS AND PRECAUTIONS (Continued) MAGNESIUM The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine. 5. CAUTION: This product requires the handling of human specimens. It is recommended that all human sourced materials be considered potentially infectious and handled in accordance with the OSHA Standard on Bloodborne Pathogens.2 Biosafety Level 23 or other appropriate biosafety practices4,5 should be used for materials that contain or are suspected of containing infectious agents. SUMMARY AND EXPLANATION OF TEST SPECIMEN COLLECTION AND HANDLING INTENDED USE Magnesium is an essential nutrient which is involved in many biochemical functions. It has a structural role in nucleic acids and ribosomal particles, required as an activator for many enzymes and has a role in energy producing oxidative phosphorylation. The normal body contains between 21 to 28 g magnesium, more than 50% of which is complexed with calcium and phosphate in bone. Only approximately 1% of the total magnesium is found in the extracellular fluid; hence, it tends to enter and leave cells under the same conditions as potassium. Approximately 35% of plasma magnesium is protein-bound, mainly to albumin, and therefore changes in albumin concentration may affect magnesium. Hypomagnesemia results in the impairment of neuromuscular function and may develop in severe prolonged diarrhea, malabsorption syndromes, hyperaldosteronism, and diuretic therapy. Hypermagnesemia is seen in renal glomerular failure and diabetic coma. Suitable Specimens Serum, plasma, and urine are acceptable specimens. • Serum: Use nonhemolyzed serum collected by standard venipuncture techniques into glass or plastic tubes with or without gel barriers. Ensure complete clot formation has taken place prior to centrifugation. Separate serum from red blood cells or gel as soon after collection as possible. Some specimens, especially those from patients receiving anticoagulant or thrombolytic therapy, may take longer to complete their clotting processes. Fibrin clots may subsequently form in these sera and the clots could cause erroneous test results. • Plasma: Use plasma collected by standard venipuncture techniques into glass or plastic tubes. Acceptable anticoagulants are lithium heparin (with or without gel barrier) and sodium heparin. Ensure centrifugation is adequate to remove platelets. Separate plasma from red blood cells or gel as soon after collection as possible. • Urine: Urine specimens should be collected in HCl, 20 to 30 mL of 6 mol/L for a 24 hour specimen, to prevent precipitation of magnesium complexes.1 PRINCIPLES OF PROCEDURE This method utilizes an arsenazo dye which binds preferentially with magnesium. The absorbance of the arsenazo-magnesium complex is measured at 572 nm and is proportional to the concentration of magnesium present in the sample. Calcium interference is prevented by incorporation of a calcium chelating agent. Methodology: Arsenazo Refer to the specimen collection tube manufacturer’s instructions for processing and handling requirements. For total sample volume requirements, refer to the instrument-specific ASSAY PARAMETERS section of this package insert and Section 5 of the instrument-specific operations manual. REAGENTS Specimen Storage Reagent Kit Serum, plasma, and urine Magnesium is supplied as a liquid, ready-to-use, single reagent kit which contains: 7D70-20 10 x 84 mL Estimated tests per kit: 3,622* Temperature Maximum Storage Bibliographic Serum/Plasma Urine* Reference 20 to 25°C 7 days 3 days 6 2 to 8°C 7 days 3 days 6, 7 -20°C 1 year 1 year 6 * Acidify to pH < 2. Guder et al.6 suggest storage of frozen specimens at -20°C for no longer than the time intervals cited above. However, limitations of laboratory equipment make it necessary in practice for clinical laboratories to establish a range around -20°C for specimen storage. This temperature range may be established from either the freezer manufacturer’s specifications or your laboratory standard operating procedure(s) for specimen storage. NOTE: Stored specimens must be inspected for particulates. If present, mix and centrifuge the specimen to remove particulates prior to testing. 7D70-30 6 x 84 mL Estimated tests per kit: 2,173* *Calculation is based on the minimum reagent fill volume per kit. Reactive Ingredients TRIS Buffer Arsenazo Dye Sodium Azide Concentration 100 mmol/L 0.13 mmol/L 0.1% REAGENT HANDLING AND STORAGE Reagent Handling PROCEDURE Remove air bubbles, if present in the reagent cartridge, with a new applicator stick. Alternatively, allow the reagent to sit at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove the bubbles. CAUTION: Reagent bubbles may interfere with proper detection of reagent level in the cartridge, causing insufficient reagent aspiration which could impact results. Materials Provided Reagent Storage Assay Procedure 7D70 Magnesium Reagent Kit Materials Required but not Provided • 1E69 Iron/Magnesium Calibrator, 3 x 5 mL • Control Material • Saline (0.85% to 0.90% NaCl) for specimens that require dilution Unopened reagents are stable until the expiration date when stored at 15 to 30°C. Reagent stability is 21 days if the reagent is uncapped and onboard. For a detailed description of how to run an assay, refer to Section 5 of the instrument-specific operations manual. Specimen Dilution Procedures WARNINGS AND PRECAUTIONS The ARCHITECT c Systems and the AEROSET System have automatic dilution features; refer to Section 2 of the instrument-specific operations manual for additional information. Serum and plasma: Specimens with magnesium values exceeding 7.8 mEq/L (3.90 mmol/L) are flagged and may be diluted using the Automated Dilution Protocol or the Manual Dilution Procedure. Urine: Urine samples are automatically diluted 1:5 by the system using the Standard dilution option, then the system automatically corrects the concentration by multiplying the result by the appropriate dilution factor. This dilution extends urine Magnesium linearity to 21.7 mEq/L (10.85 mmol/L). Samples exceeding this concentration are flagged and may be diluted using the Automated Dilution Protocol or the Manual Dilution Procedure. Precautions for Users 1. For in vitro diagnostic use. 2. Do not use components beyond the expiration date. 3. Do not mix materials from different kit lot numbers. 4. contains sodium azide. For a specific listing, refer to the REAGENTS section. Contact with acids liberates very toxic gas. This material and its container must be disposed of in a safe way. NOTE: Refer to Section 8 of the instrument-specific operations manual for proper handling and disposal of reagents containing sodium azide. 2 PROCEDURE (Continued) EXPECTED VALUES Serum/Plasma Automated Dilution Protocol If using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. To set up the automatic dilution feature, refer to Section 2 of the instrument-specific operations manual for additional information. Reference Range Serum/Plasma8 Range (mEq/L) Range (mg/dL) Range (mmol/L) Newborn, 2 to 4 days 1.2 to 1.8 1.5 to 2.2 5 months to 6 years 1.4 to 1.9 1.7 to 2.3 0.62 to 0.91 0.70 to 0.95 Urine Automated Dilution Protocol If using the Automated Dilution Protocol, the system performs a 1:10 dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. 6 to 12 years 1.4 to 1.7 1.7 to 2.1 0.70 to 0.86 12 to 20 years 1.4 to 1.8 1.7 to 2.2 0.70 to 0.91 Adult 1.3 to 2.1 1.6 to 2.6 0.66 to 1.07 Manual Dilution Procedure Manual dilutions should be performed as follows: • Use saline (0.85% to 0.90% NaCl) to dilute the sample. • The operator must enter the dilution factor in the patient or control order screen. The system uses this dilution factor to automatically correct the concentration by multiplying the result by the entered factor. • If the operator does not enter the dilution factor, the result must be multiplied by the appropriate dilution factor before reporting the result. NOTE: If a diluted sample result is flagged indicating it is less than the linear low limit, do not report the result. Rerun using an appropriate dilution. For detailed information on ordering dilutions, refer to Section 5 of the instrument-specific operations manual. NOTE: Higher values can be expected in females during menses. To convert results from mEq/L to mg/dL, multiply mEq/L by 1.215. To convert results from mEq/L to mmol/L, multiply mEq/L by 0.5. When converting the units for an assay, the following items must be edited, if applicable, using the appropriate conversion factor. • Calibrator Values • Reference Range • Qualitative/Interpretation Range • Panic/Extreme Range • Linear Range • Control Means • Retest rules ranges (ARCHITECT c Systems Only) • Constituent assay ranges for calculated assays (ARCHITECT c Systems • Min and Max Fields (AEROSET System Only) Urine8 Range (mEq/day) CALIBRATION 24 hour Calibration is stable for approximately 1 day (24 hours) and is required with each reagent cartridge and lot number change. Verify calibration with at least two levels of controls according to the established quality control requirements for your laboratory. If control results fall outside acceptable ranges, recalibration may be necessary. The urine application uses the serum calibration. For a detailed description of how to calibrate an assay, refer to Section 6 of the instrument-specific operations manual. For information on calibrator standardization, refer to the Iron/Magnesium Calibrator package insert. 6.0 to 10.0 Range (mg/day) Range (mmol/day) 72.9 to 121.5 3.00 to 5.00 To convert results from mEq/day to mmol/day, multiply mEq/day by 0.5. To convert results from mEq/day to mg/day, multiply mEq/day by 12.15. It is recommended that each laboratory determine its own reference range based upon its particular locale and population characteristics. 24 Hour Urinary Excretion To convert results from mEq/L to mEq/day (24 hour urinary excretion) Where: V = 24 hour urine volume (mL) QUALITY CONTROL c = analyte concentration (mEq/L) The following is the recommendation of Abbott Laboratories for quality control. As appropriate, refer to your laboratory standard operating procedure(s) and/or quality assurance plan for additional quality control requirements and potential corrective actions. • Two levels of controls (normal and abnormal) are to be run every 24 hours. • If more frequent control monitoring is required, follow the established quality control procedures for your laboratory. • If quality control results do not meet the acceptance criteria defined by your laboratory, patient values may be suspect. Follow the established quality control procedures for your laboratory. Recalibration may be necessary. • Review quality control results and acceptance criteria following a change of reagent or calibrator lot. 24 hour excretion = [(V × c) ÷ 1000] mEq/day To convert results from mmol/L to mmol/day (24 hour urinary excretion) Where: V = 24 hour urine volume (mL) c = analyte concentration (mmol/L) 24 hour excretion = [(V × c) ÷ 1000] mmol/day SPECIFIC PERFORMANCE CHARACTERISTICS Linearity Magnesium serum is linear up to 7.8 mEq/L or 9.5 mg/dL (3.90 mmol/L). Magnesium urine is linear up to 21.7 mEq/L or 26.4 mg/dL (10.85 mmol/L). Linearity was verified using Clinical and Laboratory Standards Institute (CLSI) protocol NCCLS EP6-P.9 RESULTS Refer to the instrument-specific operations manual for information on results calculations. • ARCHITECT System Operations Manual—Appendix C • AEROSET System Operations Manual—Appendix A Representative performance data are given in the EXPECTED VALUES and SPECIFIC PERFORMANCE CHARACTERISTICS sections of this package insert. Results obtained in individual laboratories may vary. Limit of Detection (LOD) The LOD for Magnesium serum is 0.125 mEq/L or 0.152 mg/dL (0.063 mmol/L). The LOD for Magnesium urine is 0.625 mEq/L or 0.759 mg/dL (0.313 mmol/L). The LOD is the mean concentration of an analyte-free sample + 2 SD, where SD = the pooled, within-run standard deviation of the analyte-free sample. A study performed on an ARCHITECT c System and an AEROSET System produced an LOD for Magnesium serum of 0.10 mEq/L or 0.12 mg/dL (0.050 mmol/L) and for Magnesium urine of 0.44 mEq/L or 0.53 mg/dL (0.220 mmol/L). LIMITATIONS OF THE PROCEDURE Refer to the SPECIMEN COLLECTION AND HANDLING and SPECIFIC PERFORMANCE CHARACTERISTICS sections of this package insert. Limit of Quantitation (LOQ) The LOQ for Magnesium serum is 0.54 mEq/L or 0.66 mg/dL (0.270 mmol/L). The LOQ for Magnesium urine is 1.26 mEq/L or 1.53 mg/dL (0.630 mmol/L). The LOQ is the analyte concentration at which the CV = 20%. 3 SPECIFIC PERFORMANCE CHARACTERISTICS (Continued) Interfering Method Comparison Correlation studies were performed using CLSI protocol NCCLS EP9-A.14 Serum and urine results from the Magnesium assay on the AEROSET System were compared with those from a commercially available calmagite methodology. Serum and urine results from the Magnesium assay on an ARCHITECT c System were compared with those from the Magnesium assay on the AEROSET System. Substances10 Interference studies were conducted using CLSI protocol NCCLS EP7-P.11 Interference effects were assessed by Dose Response and Paired Difference methods, at the medical decision level of the analyte. Interfering Substance Bilirubin Hemoglobin Interferent Concentration N 30 mg/dL (513 µmol/L) 3 Target Observed (mEq/L) (% of Target) 1.7 Serum 100.3 AEROSET vs. Comparative Method ARCHITECT vs. AEROSET 60 mg/dL (1,026 µmol/L) 3 1.7 96.2 N 94 84 62 mg/dL (0.62 g/L) 3 1.4 107.4 Y - Intercept 0.044 0.015 125 mg/dL (1.25 g/L) 3 1.4 118.2 Correlation Coefficient 0.993 0.998 750 mg/dL (8.5 mmol/L) 4 2.5 95.1 Slope 1.02 0.965 4 2.5 94.3 Range (mEq/L)* 0.69 to 3.96 0.20 to 7.10 AEROSET vs. Comparative Method ARCHITECT vs. AEROSET Human triglyceride 1,000 mg/dL (11.3 mmol/L) *AEROSET Range Bilirubin solutions at the above concentrations were prepared by addition of a bilirubin stock to human serum pools. Hemoglobin solutions at the above concentrations were prepared by addition of hemolysate to human serum pools. Human triglyceride solutions at the above concentrations were prepared by mixing an elevated triglyceride human serum pool with a normal triglyceride human serum pool. For the urine application, protein up to 50 mg/dL, glucose up to 1,000 mg/dL, sodium oxalate up to 60 mg/dL, ascorbate up to 200 mg/dL, boric acid up to 250 mg/dL, 6 N hydrochloric acid up to 2.5 mL/dL, 6 N nitric acid up to 5.0 mL/dL, sodium fluoride up to 400 mg/dL, and sodium carbonate up to 1.25 g/dL demonstrated less than 10% interference. 8.5 N acetic acid up to 6.25 mL/dL demonstrated 10% interference. Urine N 62 67 Y - Intercept -0.622 0.34 Correlation Coefficient 0.980 0.994 Slope 1.01 0.96 1.32 to 17.40 0.49 to 18.83 Range (mEq/L)* *AEROSET Range Precision BIBLIOGRAPHY Serum The imprecision of the Magnesium serum assay is ≤ 4% Total CV. Representative data from studies using CLSI protocol NCCLS EP5-T212 are summarized below. 1. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: WB Saunders; 1994:1913. 2. US Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational Exposure to Bloodborne Pathogens. 3. US Department of Health and Human Services. Biosafety in Microbiological and Biomedical Laboratories. HHS Publication (CDC), 4th ed. Washington, DC: US Government Printing Office, May 1999. 4. World Health Organization. Laboratory Biosafety Manual. Geneva: World Health Organization, 2004. 5. Sewell DL, Bove KE, Callihan DR, et al. Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline— Third Edition (M29-A3). Wayne, PA: Clinical and Laboratory Standards Institute, 2005. 6. Guder WG, Narayanan S, Wisser H, et al. List of analytes—preanalytical variables. Annex In: Samples: From the Patient to the Laboratory. Darmstadt, Germany: GIT Verlag; 1996:Annex 18–9, 38–9. 7. US Pharmacopeial Convention, Inc. General notices. In: US Pharmacopeia National Formulary, 1995 ed (USP 23/NF 18). Rockville, MD: The US Pharmacopeial Convention, Inc; 1994:11. 8. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 3rd ed. Philadelphia, PA: WB Saunders; 1999:1825. 9. Passey RB, Bee DE, Caffo A, et al. Evaluation of the Linearity of Quantitative Analytical Methods; Proposed Guideline (EP6-P). Villanova, PA: The National Committee for Clinical Laboratory Standards, 1986. 10. Young DS. Effects of Drugs on Clinical Laboratory Tests, 4th ed. Washington, DC: AACC Press; 1995:3-410–3-414. 11. Powers DM, Boyd JC, Glick MR, et al. Interference Testing in Clinical Chemistry; Proposed Guideline (EP7-P). Villanova, PA: The National Committee for Clinical Laboratory Standards, 1986. 12. Kennedy JW, Carey RN, Coolen RB, et al. Evaluation of Precision Performance of Clinical Chemistry Devices—Second Edition; Tentative Guideline (EP5-T2). Villanova, PA: The National Committee for Clinical Laboratory Standards, 1992. 13. Garber CC, Clark LW, Garrett PE, et al. Preliminary Evaluation of Quantitative Clinical Laboratory Methods—Second Edition; Tentative Guideline (EP10-T2). Villanova, PA: The National Committee for Clinical Laboratory Standards, 1993. 14. Kennedy JW, Carey RN, Coolen RB, et al. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline (EP9-A). Wayne, PA: The National Committee for Clinical Laboratory Standards, 1995. Control Level 1 Level 2 N 80 80 Mean (mg/dL) Within Run Between Run 1.4 4.0 SD 0.04 0.05 %CV 2.6 1.2 0.00 SD 1.01 %CV 0.6 0.0 SD 0.05 0.13 Between Day Total %CV 3.5 3.2 SD 0.06 0.14 %CV 4.4 3.4 Urine The imprecision of the Magnesium urine assay is ≤ 6% Total CV. Representative data from studies using CLSI protocol NCCLS EP10-T213 are summarized below. Control Level 1 N 50 50 Mean (mg/dL) 5.2 11.7 0.17 Within Run Between Run Level 2 SD 0.20 %CV 3.8 1.5 SD 0.00 0.05 %CV 0.0 0.4 SD 0.12 0.29 %CV 2.4 2.5 SD 0.23 0.34 %CV 4.5 2.9 TRADEMARKS AEROSET and ARCHITECT are registered trademarks of Abbott Laboratories. c System is a trademark of Abbott Laboratories. All other trademarks, brands, product names, and trade names are the property of their respective companies. Between Day Total 4 ARCHITECT c SYSTEMS ASSAY PARAMETERS Magnesium Serum/Plasma—Conventional and SI Units Configure assay parameters — SmartWash Configure assay parameters — General ● General о Calibration о SmartWash о Results о General о Calibration ● SmartWash о Results о Interpretation Assay: Mg COMPONENT REAGENT / ASSAY WASH Volume Replicates R1 CHOL0 Detergent A 345 1 R1 CK000 0.5% Acid Wash 345 1 R1 ALBG0 Detergent A 345 1 R1 ALKP0 Detergent A 345 1 R1 CO200 Detergent A 345 1 R1 GLU00 Detergent A 345 1 R1 ICTD0 0.5% Acid Wash 345 1 Cuvette Trig 10% Detergent B*** 345 *** Select “Detergent B” for software prior to Version 2.2. о Interpretation Assay: Mg Type: Photometric Version: † Number: 1009 ● Reaction definition о Reagent / Sample о Validity checks Reaction mode: End up Primary Secondary Read times Wavelength: 572 / 604 Main: 10 – 12 Last required read: 12 Absorbance range: ___–___ Color Correction: ___–___ Sample blank type: None о Reaction definition Reagent: MG000 Diluent: Saline Diluent dispense mode: Type 0 Diluted Dilution name Sample sample STANDARD : 2.4 ___ _________ : ___ ___ _________ : ___ ___ ● Reagent / Sample о Validity checks Reagent volume: Water volume: Dispense mode: Diluent ___ ___ ___ о Reaction definition Reaction check: None R1 200 ___ Type 0 Water Dilution factor ___ = 1:1.00 ___ = ___ = Magnesium Serum/Plasma—Conventional Units Configure assay parameters — Results — Conventional Units о General о SmartWash ● Results о Interpretation Assay: Mg Result units: mEq/L Assay defaults: ‡ Low-Linearity: 0.6 High-Linearity: 7.8 Gender and age specific ranges:* GENDER AGE (UNITS) NORMAL EXTREME Either 0 – 130 (Y) 1.3 – 2.1 Default dilution ● о о о Reagent / Sample ● Validity checks Configure result units — Conventional Units Maximum absorbance variation: ___ Assay: Version: Result units: Decimal places: Correlation factor: Intercept: Configure assay parameters — Calibration о General Assay: ● Calibration о SmartWash о Results Mg ● Calibrators Calibrator set: FeMg Replicates: 3 о Calibrators [Range 1 – 3] о Intervals Calibrator level: Blank: Water Cal 1: FeMg1 Cal 2: FeMg2 ● Volumes о Intervals Calibrator: FeMg Calibrator level Blank: Water Cal 1: FeMg1 Cal 2: FeMg2 о Calibrators о Volumes Calibration intervals: Full interval: 24 Calibration type: Adjust type: None о Calibrators о Volumes Blank absorbance range: Span: Span absorbance range: Expected cal factor: Expected cal factor tolerance %: * † ‡ †† ‡‡ о Interpretation Calibration method: Linear о Volumes Sample 2.4 2.4 2.4 Diluted sample ___ ___ ___ ● Intervals о Calibration Mg 8 mEq/L 1 [Range 0 – 4] 1.0000 0.0000 о Validity checks Concentration: 0‡‡ †† †† Magnesium Serum/Plasma—SI Units Configure assay parameters — Results — SI Units о General о SmartWash ● Results о Interpretation Assay: Mg Result units: mmol/L Assay defaults: Low-Linearity: 0.27‡ High-Linearity: 3.90 Gender and age specific ranges:* GENDER AGE (UNITS) NORMAL EXTREME Either 0 – 130 (Y) 0.66 – 1.07 о Validity checks Diluent ___ ___ ___ Water ___ ___ ___ о Calibration о Validity checks (hours) Configure result units — SI Units о Intervals Assay: Version: Result units: Decimal places: Correlation factor: Intercept: ● Validity checks _____ – _____ Blank – Blank _____ – _____ 0.00 0 Mg 5 mmol/L 2 [Range 0 – 4] 1.0000 0.0000 User defined. The respective assay versions for Conventional and SI Units are listed in the Configure result units screens on this page. The linear low value (Low-Linearity) is LOQ rounded up to the number of decimal places defined in the decimal places parameter field. Refer to concentration specified on calibrator labeling or value sheet. Displays the number of decimal places defined in the decimal places parameter field. 5 ARCHITECT c SYSTEMS ASSAY PARAMETERS Magnesium Urine—Conventional and SI Units Configure assay parameters — General ● General Configure assay parameters — SmartWash о Calibration о SmartWash о Results о Interpretation о General о Calibration ● SmartWash о Results о Interpretation Assay: Mg-U COMPONENT REAGENT / ASSAY WASH Volume Replicates R1 CHOL0 Detergent A 345 1 R1 CK000 0.5% Acid Wash 345 1 R1 ALBG0 Detergent A 345 1 R1 ALKP0 Detergent A 345 1 R1 CO200 Detergent A 345 1 R1 GLU00 Detergent A 345 1 R1 ICTD0 0.5% Acid Wash 345 1 Cuvette Trig 10% Detergent B*** 345 *** Select “Detergent B” for software prior to Version 2.2. Assay: Mg-U Type: Photometric Version: † Number: 1040 ● Reaction definition о Reagent / Sample о Validity checks Reaction mode: End up Primary Secondary Read times Wavelength: 572 / 604 Main: 10 – 12 Last required read: 12 Absorbance range: ___–___ Color Correction: ___–___ Sample blank type: None о Reaction definition Reagent: MG000 Diluent: Saline Diluent dispense mode: Type 0 Diluted Dilution name Sample sample STD(1:5) : 30.0 2.4 1:10 : 15.0 2.4 _________ : ___ ___ о Reaction definition Reaction check: None ● Reagent / Sample о Validity checks Reagent volume: Water volume: Dispense mode: Diluent 120 135 ___ R1 200 ___ Type 0 Water Dilution factor ___ = 1:5.00 ___ = 1:10.00 ___ = Magnesium Urine—Conventional Units Configure assay parameters — Results — Conventional Units о General о SmartWash ● Results о Interpretation Assay: Mg-U Result units: mEq/L Assay defaults: ‡ Low-Linearity: 0.3 High-Linearity: 4.3‡ Gender and age specific ranges: GENDER AGE (UNITS) NORMAL EXTREME Default dilution ● о о о Reagent / Sample ● Validity checks Configure result units — Conventional Units Maximum absorbance variation: ___ Assay: Version: Result units: Decimal places: Correlation factor: Intercept: Configure assay parameters — Calibration о General Assay: ● Calibration о SmartWash о Results Mg-U о Calibration о Interpretation Calibration method: Use Cal Factor/Blank Use Cal factor from: Mg Mg-U 8 mEq/L 1 [Range 0 – 4] 1.0000 0.0000 Magnesium Urine—SI Units Configure assay parameters — Results — SI Units о General о Calibration о SmartWash ● Results о Interpretation Assay: Mg-U Result units: mmol/L Assay defaults: Low-Linearity: 0.13‡ High-Linearity: 2.17‡ Gender and age specific ranges: GENDER AGE (UNITS) NORMAL EXTREME Configure result units — SI Units Assay: Version: Result units: Decimal places: Correlation factor: Intercept: † ‡ Mg-U 5 mmol/L 2 [Range 0 – 4] 1.0000 0.0000 The respective assay versions for Conventional and SI Units are listed in the Configure result units screens on this page. The linear low value (Low-Linearity) is LOQ divided by the Standard dilution factor, then rounded up to the number of decimal places defined in the decimal places parameter field. The linear high value (High-Linearity) is Linearity divided by the Standard dilution factor. 6 AEROSET SYSTEM ASSAY PARAMETERS Magnesium Serum/Plasma—Conventional Units Magnesium Serum/Plasma—SI Units Assay Configuration: Outline Page Assay Configuration: Outline Page Assay Name Assay # Mg 9 Quantitative Ranges Min Text Min Panic-L * 0.0* L-Reference-H 0.0 0.6** 1.3 2.1 L-Linear Range-H Reference Ranges* Age 0.0 0.0 0.0 0.0 0 Year 0 Year 0 Year Qualitative Ranges Assay Name Assay # Mg 9 Quantitative Ranges Min Text Min Panic-L Line B-Line Male – – – – 0.0 0.0 0.0 0.0 Panic-H Max 0.0 7.8 0.0* 0.0 0.0 0.0 0.0 Max Text * * Female – 0.0 – 0.0 – 0.0 – 0.0 0.0* 0.66 1.07 L-Linear Range-H 0.0 0.0 0.0 0.0 0 Year 0 Year 0 Year Qualitative Ranges Male – – – – 0.0 0.0 0.0 0.0 Panic-H Max 0.0 3.90 0.0 0.0 0.0 0.0 0.0* Female – 0.0 – 0.0 – 0.0 – 0.0 Assay Configuration: Base Page Wavelength-Prim/ Read time-Main/Flex AbsMaxVar Sec END UP 572 / 604 10 – 12 / 0 – 0 0.0 Sample Blank Test Blank Read Time Abs Window Abs Limits _____ ( ___ ) 0–0 0–0 0.0 – 0.0 S.Vol DS.Vol D.Vol W.Vol Standard 2.4 0.0 0 0 Rgt Name/Pos Dil 1 2.4 0.0 0 0 Diluent: _____ _–__* Dil 2 2.4 0.0 0 0 Type# 0 Rgt Name/Pos R.Vol W.Vol Type# Reagent 1 MG00061 – ___* 200 0 0 Reaction Check Read Time – A/B Range Minimum ____________ 1–1/1–1 0.0 – 0.0 0.0 Factor/Intercept Decimal Places Units 1.0 / 0.0 2 mmol/L Reaction Mode Assay Configuration: Calibration Page Assay Configuration: Calibration Page Calib Mode Linear Blank/Calib Replicates 3/3 Sample S.Vol BLK Water 2.4 C1 FeMg 1 2.4 C2 FeMg 2 2.4 Interval (H) 24 Span Span Abs Range BLK – 1 0.0 – 0.0 W.Vol Blk Abs Range 0 0.0 – 0.0 0 Cal Deviation 0 0.0 FAC Limit (%) 10 Assay Configuration: SmartWash Page Extrapolation % 0 DS.Vol D.Vol 0.0 0 0.0 0 0.0 0 Interval (H) 24 Span Span Abs Range BLK – 1 0.0 – 0.0 W.Vol Blk Abs Range 0 0.0 – 0.0 0 Cal Deviation 0 0.0 FAC Limit (%) 10 Assay Configuration: SmartWash Page Rgt Probe Rgt Probe Reagent ALKP061 ALBG061 CHOL061 CK00061 CO20051 GLU0061 ICTD061 ALKP051 CO2C951 CO2C961 Wash AlkW AlkW AlkW AlkW AlkW Water AcidW AlkW AlkW AlkW Vol 345 345 345 345 345 345 345 345 345 345 Reagent ALKP061 ALBG061 CHOL061 CK00061 CO20051 GLU0061 ICTD061 ALKP051 CO2C951 CO2C961 Cuvette Wash AlkW AlkW AlkW AlkW AlkW Water AcidW AlkW AlkW AlkW Vol 345 345 345 345 345 345 345 345 345 345 Cuvette Assay Name — Wash — Max Text * N/A Assay Configuration: Base Page Wavelength-Prim/ Read time-Main/Flex AbsMaxVar Sec END UP 572 / 604 10 – 12 / 0 – 0 0.0 Sample Blank Test Blank Read Time Abs Window Abs Limits _____ ( ___ ) 0–0 0–0 0.0 – 0.0 S.Vol DS.Vol D.Vol W.Vol Standard 2.4 0.0 0 0 Rgt Name/Pos Dil 1 2.4 0.0 0 0 Diluent: _____ _–__* Dil 2 2.4 0.0 0 0 Type# 0 Rgt Name/Pos R.Vol W.Vol Type# Reagent 1 MG00061 – ___* 200 0 0 Reaction Check Read Time – A/B Range Minimum ____________ 1–1/1–1 0.0 – 0.0 0.0 Factor/Intercept Decimal Places Units 1.0 / 0.0 1 mEq/L Reaction Mode Extrapolation % 0 DS.Vol D.Vol 0.0 0 0.0 0 0.0 0 L-Reference-H 0.0 0.27** Reference Ranges* Age N/A Calib Mode Linear Blank/Calib Replicates 3/3 Sample S.Vol BLK Water 2.4 C1 FeMg 1 2.4 C2 FeMg 2 2.4 Line B-Line Vol — Assay Name — Sample Probe Wash — Vol — Sample Probe Wash — Wash — Refer to Assay Configuration in Section 2 of the AEROSET System Operations Manual for information regarding assay parameters. * User defined or instrument defined. ** The linear low value (L-Linear Range) is LOQ rounded up to the number of decimal places defined in the decimal places parameter field. 7 AEROSET SYSTEM ASSAY PARAMETERS Magnesium Urine—Conventional Units Magnesium Urine—SI Units Assay Configuration: Outline Page Assay Configuration: Outline Page Assay Name Assay # Mg-U 40 Quantitative Ranges Min Text Min Panic-L * 0.0* L-Reference-H 0.0 0.3** 0.0 0.0 L-Linear Range-H Reference Ranges* Age 0.0 0.0 0.0 0.0 0 Year 0 Year 0 Year Qualitative Ranges Assay Name Assay # Mg-U 40 Quantitative Ranges Min Text Min Panic-L Line B-Line Male – – – – 0.0 0.0 0.0 0.0 Panic-H Max 0.0 4.3** 0.0 0.0 0.0 0.0 0.0* Max Text * * Line B-Line L-Reference-H 0.0 0.13** Reference Ranges* Age Female – 0.0 – 0.0 – 0.0 – 0.0 0.0* 0.0 0.0 L-Linear Range-H 0.0 0.0 0.0 0.0 0 Year 0 Year 0 Year Qualitative Ranges N/A Male – – – – 0.0 0.0 0.0 0.0 Panic-H Max 0.0 0.0* 2.17** 0.0 0.0 0.0 0.0 Max Text * Female – 0.0 – 0.0 – 0.0 – 0.0 N/A Assay Configuration: Base Page Assay Configuration: Base Page Wavelength-Prim/ Read time-Main/Flex AbsMaxVar Sec END UP 572 / 604 10 – 12 / 0 – 0 0.0 Sample Blank Test Blank Read Time Abs Window Abs Limits _____ ( ___ ) 0–0 0–0 0.0 – 0.0 S.Vol DS.Vol D.Vol W.Vol Standard 30.0 2.4 120 0 Rgt Name/Pos Dil 1 15.0 2.4 135 0 Diluent: DILUENT D–18* Dil 2 30.0 2.4 120 0 Type# 0 Rgt Name/Pos R.Vol W.Vol Type# Reagent 1 MG00061 – ___* 200 0 0 Reaction Check Read Time – A/B Range Minimum ____________ 1–1/1–1 0.0 – 0.0 0.0 Factor/Intercept Decimal Places Units 1.0 / 0.0 1 mEq/L Wavelength-Prim/ Read time-Main/Flex AbsMaxVar Sec END UP 572 / 604 10 – 12 / 0 – 0 0.0 Sample Blank Test Blank Read Time Abs Window Abs Limits _____ ( ___ ) 0–0 0–0 0.0 – 0.0 S.Vol DS.Vol D.Vol W.Vol Standard 30.0 2.4 120 0 Rgt Name/Pos Dil 1 15.0 2.4 135 0 Diluent: DILUENT D–18* Dil 2 30.0 2.4 120 0 Type# 0 Rgt Name/Pos R.Vol W.Vol Type# Reagent 1 MG00061 – ___* 200 0 0 Reaction Check Read Time – A/B Range Minimum ____________ 1–1/1–1 0.0 – 0.0 0.0 Factor/Intercept Decimal Places Units 1.0 / 0.0 2 mmol/L Reaction Mode Reaction Mode Assay Configuration: Calibration Page Assay Configuration: Calibration Page Calib Mode UseFac/Blk Blank/Calib Replicates 0/0 Sample S.Vol BLK 2.0 C1 2.0 C2 2.0 Use Cal Factor from Mg ( 9 ) Extrapolation % 0 DS.Vol D.Vol 0.0 0 0.0 0 0.0 0 Calib Mode UseFac/Blk Blank/Calib Replicates 0/0 Sample S.Vol BLK 2.0 C1 2.0 C2 2.0 Interval (H) 0 Span Span Abs Range BLK – 1 0.0 – 0.0 W.Vol Blk Abs Range 0 0.0 – 0.0 0 Cal Deviation 0 0.0 Assay Configuration: SmartWash Page Use Cal Factor from Mg ( 9 ) Extrapolation % 0 DS.Vol D.Vol 0.0 0 0.0 0 0.0 0 Interval (H) 0 Span Span Abs Range BLK – 1 0.0 – 0.0 W.Vol Blk Abs Range 0 0.0 – 0.0 0 Cal Deviation 0 0.0 Assay Configuration: SmartWash Page Rgt Probe Rgt Probe Reagent ALKP061 ALBG061 CHOL061 CK00061 CO20051 GLU0061 ICTD061 ALKP051 CO2C951 CO2C961 Wash AlkW AlkW AlkW AlkW AlkW Water AcidW AlkW AlkW AlkW Vol 345 345 345 345 345 345 345 345 345 345 Reagent ALKP061 ALBG061 CHOL061 CK00061 CO20051 GLU0061 ICTD061 ALKP051 CO2C951 CO2C961 Cuvette Wash AlkW AlkW AlkW AlkW AlkW Water AcidW AlkW AlkW AlkW Vol 345 345 345 345 345 345 345 345 345 345 Cuvette Assay Name — Wash — Vol — Assay Name — Sample Probe Wash — Vol — Sample Probe Wash — Wash — Refer to Assay Configuration in Section 2 of the AEROSET System Operations Manual for information regarding assay parameters. * User defined or instrument defined. ** The linear low value (L-Linear Range) is LOQ divided by the Standard dilution factor, then rounded up to the number of decimal places defined in the decimal places parameter field. The linear high value (Linear Range-H) is Linearity divided by the Standard dilution factor. 8